Brief: Precipio Announces Commercial Launch Of Covid-19 Antibody Test
July 30 (Reuters) - Precipio Inc PRPO.O :
* PRECIPIO ANNOUNCES COMMERCIAL LAUNCH OF COVID-19 ANTIBODY
TEST
* PRECIPIO INC - ENTERED INTO AGREEMENT WITH ADS BIOTEC TO
DISTRIBUTE ITS FDA-AUTHORIZED COVID-19 SEROLOGY ANTIBODY TESTS
THAT RECENTLY RECEIVED EUA
Source text for Eikon: urn:newsml:reuters.com:*:nGNX7Lr8Mb
Further company coverage: PRPO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precipio
See all newsCancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive
Precipio Q1 revenue rises on higher pathology sales
Blood cancer diagnostics firm Precipio's prelim Q4 revenue rises 23%
Brief: Precipio Identifies Unauthorized Access To Isolated Storage No Operational Impact
Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers